Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: Data from the OPTIMAAL trial

Stefan D. Anker, Adriaan Voors, Darlington Okonko, Andrew L. Clark, Margaret K. James, Stephan Von Haehling, John Kjekshus, Piotr Ponikowski, Kenneth Dickstein

Research output: Contribution to journalArticle

Abstract

AimsThe prevalence, incidence, and prognostic value of anaemia in patients with an acute myocardial infarction (AMI) complicated by heart failure is unclear.Methods and resultsWe analysed the relationship between haemoglobin (Hb) and outcome in 5010 patients with AMI complicated by heart failure in the OPTIMAAL study. In 3921 patients, follow-up Hb levels were available at 365 (±90) days. In a subgroup of 224 patients, iron-related haematinics were assessed at baseline and during follow-up. At baseline, mean Hb was 12.6 ± 1.3 g/dL in women and 13.7 ± 1.4 g/dL in men. Hb <11.5 g/dL was found in 9.3 of patients (women: 18.2, men: 5.8). Lower haemoglobin at baseline was clearly associated with female gender and the presence of diabetes, higher age and Killip class, lower body mass index, systolic blood pressure, total cholesterol, and the absence of current smoking (all P <0.05). Higher Hb [per one standard deviation (SD)] related to lower mortality [adjusted hazard ratios (HR) 0.88; 95 confidence interval (CI) 0.83-0.93], CHF hospitalizations [HR 0.85 (0.77-0.93)], and all-cause hospitalizations [HR 0.96 (0.92-0.99), all P <0.05]. In patients without anaemia at baseline, the anaemia incidence after 1 year of follow-up was 10.1 in women and 10.0 in men. Of patients with anaemia at baseline, 65 did not have anaemia at 12 months and 46 did not have anaemia at any time during follow-up (median 3.0 years, inter-quartile range, Q1-Q3 = 2.7-3.3 years). At 12 months, an increase in Hb (per SD) was related to lower mortality [HR 0.73 (0.63-0.85; P <0.0001)] independent of baseline Hb and other clinical characteristics.ConclusionIn patients with complicated AMIs, anaemia on admission and/or reductions in haemoglobin during follow-up are independent risk factors for mortality and hospitalization. Studies are warranted to determine whether correcting anaemia after a complicated AMI improves outcome.

Original languageEnglish
Pages (from-to)1331-1339
Number of pages9
JournalEuropean Heart Journal
Volume30
Issue number11
DOIs
Publication statusPublished - Jun 2009

Keywords

  • Anaemia
  • Erythropoietin
  • Hospitalization
  • Iron deficiency
  • Mortality
  • Myocardial infarction
  • OPTIMAAL study

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: Data from the OPTIMAAL trial'. Together they form a unique fingerprint.

  • Cite this

    Anker, S. D., Voors, A., Okonko, D., Clark, A. L., James, M. K., Von Haehling, S., Kjekshus, J., Ponikowski, P., & Dickstein, K. (2009). Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: Data from the OPTIMAAL trial. European Heart Journal, 30(11), 1331-1339. https://doi.org/10.1093/eurheartj/ehp116